Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shayan Dioun

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Familial Cancer|February 18, 2026
Misinterpreting the results: patient misconceptions about genetic cancer risk after obstetrical carrier screeningAlex Raghunandan, Sonali Iyer, Shayan Dioun, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 28, 2021
Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancerShayan Dioun, Ling Chen, Alexander Melamed, et al.
Gynecologic Oncology|January 23, 2024
Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapyShayan Dioun, Ling Chen, Alexandre Buckley De Meritens, et al.
Obstetrics and Gynecology|October 7, 2021
Trends in the Use of Minimally Invasive Adnexal Surgery in the United StatesShayan Dioun, Yongmei Huang, Alexander Melamed, et al.
Gynecologic Oncology|May 23, 2017
A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancerPamela T Soliman, Shannon N Westin, Shayan Dioun, et al.
Obstetrics and Gynecology|April 8, 2021
Uptake and Outcomes of Sentinel Lymph Node Mapping in Women With Atypical Endometrial HyperplasiaShayan Dioun, Ling Chen, Alexander Melamed, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 4, 2022
Dostarlimab for recurrent mismatch repair-deficient endometrial cancer: A cost-effectiveness studyShayan Dioun, Ling Chen, Alexander Melamed, et al.
Gynecologic Oncology|January 17, 2026
Trends, predictors, and safety of ovarian preservation in premenopausal women with high-grade endometrioid and non-endometrioid endometrial cancersJaida E Morgan, Ling Chen, Xiao Xu, et al.
Gynecologic Oncology|May 6, 2026
Impact of lymphadenectomy on survival outcomes for stage I malignant ovarian germ cell tumorsDelanie Ludmir, Yongmei Huang, Xiao Xu, et al.
Cancer|June 22, 2019
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective studyKatherine I Stewart, Beth Chasen, William Erwin, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Familial Cancer|February 18, 2026
Misinterpreting the results: patient misconceptions about genetic cancer risk after obstetrical carrier screeningAlex Raghunandan, Sonali Iyer, Shayan Dioun, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 28, 2021
Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancerShayan Dioun, Ling Chen, Alexander Melamed, et al.
Gynecologic Oncology|January 23, 2024
Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapyShayan Dioun, Ling Chen, Alexandre Buckley De Meritens, et al.
Obstetrics and Gynecology|October 7, 2021
Trends in the Use of Minimally Invasive Adnexal Surgery in the United StatesShayan Dioun, Yongmei Huang, Alexander Melamed, et al.
Gynecologic Oncology|May 23, 2017
A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancerPamela T Soliman, Shannon N Westin, Shayan Dioun, et al.
Obstetrics and Gynecology|April 8, 2021
Uptake and Outcomes of Sentinel Lymph Node Mapping in Women With Atypical Endometrial HyperplasiaShayan Dioun, Ling Chen, Alexander Melamed, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 4, 2022
Dostarlimab for recurrent mismatch repair-deficient endometrial cancer: A cost-effectiveness studyShayan Dioun, Ling Chen, Alexander Melamed, et al.
Gynecologic Oncology|January 17, 2026
Trends, predictors, and safety of ovarian preservation in premenopausal women with high-grade endometrioid and non-endometrioid endometrial cancersJaida E Morgan, Ling Chen, Xiao Xu, et al.
Gynecologic Oncology|May 6, 2026
Impact of lymphadenectomy on survival outcomes for stage I malignant ovarian germ cell tumorsDelanie Ludmir, Yongmei Huang, Xiao Xu, et al.
Cancer|June 22, 2019
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective studyKatherine I Stewart, Beth Chasen, William Erwin, et al.
Pageof 3